ClinVar Miner

Variants from CZECANCA consortium

Location: Czechia  Primary collection method: clinical testing
Minimum submission review status: Collection method:
Minimum conflict level:
Gene type:
ClinVar version:

If a variant has more than one submission, it may be counted in more than one significance column. If this is the case, the total number of variants will be less than the sum of the other cells.

pathogenic likely pathogenic uncertain significance likely benign benign total
196 30 0 0 0 224

Gene and significance breakdown #

Total genes and gene combinations: 27
Download table as spreadsheet
Gene or gene combination pathogenic likely pathogenic total
BRCA2 55 0 55
BRCA1 44 1 45
MSH6 13 1 14
CHEK2 7 5 12
BRCA1, LOC126862571 11 0 11
BRIP1 9 0 9
ATM, C11orf65 5 3 8
MLH1 8 0 8
PALB2 7 0 7
RAD50 4 4 7
RAD51D, RAD51L3-RFFL 6 1 7
MSH2 4 2 6
NBN 6 1 6
ATM 5 0 5
TP53 3 2 5
BARD1 3 1 4
RAD51C 2 2 4
PTEN 1 1 2
ERCC4 0 1 1
FANCE 1 0 1
FANCG 0 1 1
FH 0 1 1
HOXB13 0 1 1
LOC129390903, RAD51C 1 0 1
PMS2 0 1 1
POLD1 1 0 1
RET 0 1 1

Condition and significance breakdown #

Total conditions: 5
Download table as spreadsheet
Condition pathogenic likely pathogenic total
Breast and/or ovarian cancer 153 15 168
Endometrial carcinoma 31 1 32
Carcinoma of pancreas 24 5 29
Uterine corpus cancer 12 3 15
Hepatocellular carcinoma 0 7 7

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.